(Q46484975)

English

Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

author name string

Jay S Dela Cruz

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

Sherie L Morrison

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

Manuel L Penichet

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

23

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

39

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

4793-4803

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

Her-2/neu and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Biology of HER2 and its importance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

ErbB2 immune response in breast cancer patients with soluble receptor ectodomain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Fc receptors are required in passive and active immunity to melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

B cell-dependent TCR diversification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Immune complexes can trigger specific, T cell-dependent, autoanti-IgG antibody production in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.041

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.04.041

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15967544

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46484975&oldid=2113453417"